Indication
Philadelphia chromosome positive chronic myelocytic leukemia
Philadelphia chromosome positive chronic myelocytic leukemia (also termed chronic myeloid or myelogenous leukemia) is a clonal myeloproliferative neoplasm affecting the hematopoietic system, predominantly diagnosed in older adults. Read more about Philadelphia chromosome positive chronic myelocytic leukemia
0 drugs 0 manufacturers
Drugs that treat it
Common Philadelphia chromosome positive chronic myelocytic leukemia therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPhiladelphia chromosome positive chronic myelocytic leukemia (also termed chronic myeloid or myelogenous leukemia) is a clonal myeloproliferative neoplasm affecting the hematopoietic system, predominantly diagnosed in older adults.
It is defined by the presence of the Philadelphia chromosome, an acquired cytogenetic abnormality resulting from a reciprocal translocation between chromosomes 9 and 22, t(9;22)(q34;q11.2).
This genetic alteration produces the constitutively active BCR::ABL1 tyrosine kinase fusion oncoprotein, which drives the uncontrolled proliferation and accumulation of mature and maturing granulocytic cells in the bone marrow and peripheral blood.
Patients classically present with marked leukocytosis, anemia, and splenomegaly, with the potential to progress from an indolent chronic phase to an aggressive blastic phase.
- nih.gov
Philadelphia chromosome positive chronic myelocytic leukemia (also termed chronic myeloid or myelogenous leukemia) is a clonal myeloproliferative neoplasm affecting the hematopoietic system, predominantly diagnosed in older adults It is defined by the presence of the Philadelphia chromosome, an acquired cytogenetic abnormality resulting from a reciprocal translocation between chromosomes 9 and 22, t(9;22)(q34;q11.2) This genetic alteration produces the constitutively active BCR::ABL1 tyrosine ki...
- medlineplus.gov
Philadelphia chromosome positive chronic myelocytic leukemia (also termed chronic myeloid or myelogenous leukemia) is a clonal myeloproliferative neoplasm affecting the hematopoietic system, predominantly diagnosed in older adults
- nih.gov
Philadelphia chromosome positive chronic myelocytic leukemia (also termed chronic myeloid or myelogenous leukemia) is a clonal myeloproliferative neoplasm affecting the hematopoietic system, predominantly diagnosed in older adults This genetic alteration produces the constitutively active BCR::ABL1 tyrosine kinase fusion oncoprotein, which drives the uncontrolled proliferation and accumulation of mature and maturing granulocytic cells in the bone marrow and peripheral blood Patients classically ...
- nih.gov
It is defined by the presence of the Philadelphia chromosome, an acquired cytogenetic abnormality resulting from a reciprocal translocation between chromosomes 9 and 22, t(9;22)(q34;q11.2) This genetic alteration produces the constitutively active BCR::ABL1 tyrosine kinase fusion oncoprotein, which drives the uncontrolled proliferation and accumulation of mature and maturing granulocytic cells in the bone marrow and peripheral blood
- nih.gov
Patients classically present with marked leukocytosis, anemia, and splenomegaly, with the potential to progress from an indolent chronic phase to an aggressive blastic phase
- cancer.gov
Patients classically present with marked leukocytosis, anemia, and splenomegaly, with the potential to progress from an indolent chronic phase to an aggressive blastic phase
Personalize your experience
Follow Philadelphia chromosome positive chronic myelocytic leukemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.